Atherosclerosis (AS) is a chronic inflammatory disease characterized by the buildup of lipids and immune cells in arterial ...

Researchers from CHU Nîmes, Université Montpellier, and multiple MS centers in France have found that oral cholecalciferol in ...

Asthma and atopic dermatitis are chronic inflammatory diseases of the airways and the skin, respectively, which affect hundreds of millions of children and adults globally. Most patients with asthma ...

A new clinical trial has shown for the first time that taking high doses of vitamin D could stave off the progression of ...

Systemic sclerosis (SSc) is a complex autoimmune disease characterized by widespread vascular abnormalities, immune system activation, and skin and internal ...

A new study validates the Scleroderma Skin Questionnaire (SSQ) as a reliable tool for assessing skin symptoms in systemic ...

With $75.1 million in cash and minimal competition, aTyr Pharma is well-positioned financially, making it a compelling ...

Topline data from Phase 3 EFZO-FIT study of efzofitimod in pulmonary sarcoidosis expected in the third quarter of 2025. Fourth positive DSMB review for efzofitimod in Phase 3 EFZO-FIT study reinforces ...

Topline data from Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis expected in the third quarter of 2025.

Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the "Company" or "Quoin"), a late clinical-stage specialty pharmaceutical company focused on rare and orphan ...

About Quoin Pharmaceuticals Ltd. Quoin Pharmaceuticals Ltd. is a late ... including Netherton Syndrome, Peeling Skin Syndrome ...

Researcher and developer of its leading proprietary all-natural anti-microbial SE Formula Biotechnology. The SE Formula Biotechnology is used as a base in the Company's proprietary skincare ...